Ru Jia

机构：Pharmaceutical Biotechnology (Czechia), State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University · ORCID：0000-0002-8121-4443

发表论文 26 篇 · 总被引 98 次 · h-index 6

代表论文

• FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer (2022 · Journal for ImmunoTherapy of Cancer · 被引 27)
• Mannose‐targeting Concanavalin A−Epirubicin Conjugate for Targeted Intravesical Chemotherapy of Bladder Cancer (2022 · Chemistry - An Asian Journal · 被引 24)
• Targeted Delivery of Catalase and Photosensitizer Ce6 by a Tumor-Specific Aptamer Is Effective against Bladder Cancer In Vivo (2024 · Molecular Pharmaceutics · 被引 13)
• Gut Microbiota–Mediated Bile Acid Metabolism Regulates Colorectal Cancer Liver Metastasis by Altering Neutrophil Recruitment (2025 · Cancer Research · 被引 12)
• HSD17B13 liquid–liquid phase separation promotes leukocyte adhesion in chronic liver inflammation (2024 · Journal of Molecular Cell Biology · 被引 12)
• In Situ Translation of Terminal Glycans into Covalent Readouts in Complex Biological Systems (2026 · Analytical Chemistry)